Truist Financial Corp Novo Cure LTD Transaction History
Truist Financial Corp
- $62.7 Billion
- Q4 2024
A detailed history of Truist Financial Corp transactions in Novo Cure LTD stock. As of the latest transaction made, Truist Financial Corp holds 11,422 shares of NVCR stock, worth $256,766. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,422Holding current value
$256,766% of portfolio
0.0%Shares
13 transactions
Others Institutions Holding NVCR
# of Institutions
290Shares Held
75.2MCall Options Held
1.81MPut Options Held
464K-
Black Rock Inc. New York, NY12.1MShares$273 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$265 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$199 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$108 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$61.6 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.36B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...